Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ghezzi

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Neuroimage|January 27, 2005
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRIMarco Rovaris, Antonio Gallo, Paola Valsasina, et al.
Journal of Neuroimmunology|December 1, 2010
MGAT5 and disease severity in progressive multiple sclerosisFederica Esposito, Jerome Wojcik, Mariaemma Rodegher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Different MRI patterns in MS worsening after stopping fingolimodCaterina Lapucci, Damiano Baroncini, Maria Cellerino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesionsMaria A Rocca, Ermelinda De Meo, Maria P Amato, et al.
Neurology|August 20, 2017
MRI substrates of sustained attention system and cognitive impairment in pediatric MS patientsErmelinda De Meo, Lucia Moiola, Angelo Ghezzi, et al.
Plos One|April 16, 2014
MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patientsFederico Serana, Luisa Imberti, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2009
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experienceAngelo Ghezzi, Maria Pia Amato, Pietro Annovazzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 6, 2013
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patientsMassimo Filippi, Maria A Rocca, Stefano Bastianello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerationsAngelo Ghezzi, Brenda Banwell, Amit Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 15, 2016
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypesLuis Ruano, Emilio Portaccio, Benedetta Goretti, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Neuroimage|January 27, 2005
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRIMarco Rovaris, Antonio Gallo, Paola Valsasina, et al.
Journal of Neuroimmunology|December 1, 2010
MGAT5 and disease severity in progressive multiple sclerosisFederica Esposito, Jerome Wojcik, Mariaemma Rodegher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Different MRI patterns in MS worsening after stopping fingolimodCaterina Lapucci, Damiano Baroncini, Maria Cellerino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Cognitive impairment in paediatric multiple sclerosis patients is not related to cortical lesionsMaria A Rocca, Ermelinda De Meo, Maria P Amato, et al.
Neurology|August 20, 2017
MRI substrates of sustained attention system and cognitive impairment in pediatric MS patientsErmelinda De Meo, Lucia Moiola, Angelo Ghezzi, et al.
Plos One|April 16, 2014
MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patientsFederico Serana, Luisa Imberti, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2009
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experienceAngelo Ghezzi, Maria Pia Amato, Pietro Annovazzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 6, 2013
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patientsMassimo Filippi, Maria A Rocca, Stefano Bastianello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerationsAngelo Ghezzi, Brenda Banwell, Amit Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 15, 2016
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypesLuis Ruano, Emilio Portaccio, Benedetta Goretti, et al.
Pageof 14